Research Article

Clinical Stages in Patients with Primary and Subsequent Cancers Based on the Czech Cancer Registry 1976–2005

Table 1

New cancers and multiple malignant cases based on the Czech Cancer Registry 1976–2005 (up to October 17, 2007, data in 1976 from May).

Malignant neoplasmICD-10MenWomen
New MN% (a)MMNs% (b)New MN% (a)MMNs% (b)

Oral cavity, pharynxC00-14206732,820703,262410,95400,9
Gastrointestinal tract C15-2619354725,6886213,616207722,258829,8
Respiratory tractC30-3916231521,450937,7322634,48871,5
Bone, articular cartilageC40-4117650,2700,113200,2500,1
Melanoma of skinC43143311,916262,5153272,115182,5
SkinC4413472717,8300124612978717,82360439,4
Mesothelial, soft tissueC45-4954890,73210,551770,72670,4
BreastC509780,11280,211854616,21035217,3
Female genital organsC51-58000011591215,9878514,7
Male genital organs C60-63745609,852658,10000
Urinary tract C64-68675308,962789,6328074,522213,7
Eye, brain, nervous systemC69-72107341,43050,591301,32860,5
Thyroid and other glandsC73-7532480,42220,393571,35851
Unspecified sitesC76-80135391,83920,6139511,93230,5
Lymphoid, haematol. tissueC81-96400715,326674,1350564,816972,8

In situ D00-097438111611,8351924,823013,8
Uncertain behaviourD37-4864490,98201,3744716721,1

Total sitesC00-D48757394 1006529210072959010059970100

% (a): relevant diagnosis in percent of all new cancers.
% (b): relevant diagnosis in percent of all malignant neoplasms.